Corcept Therapeutics (CORT) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $117.51 +0.01%
EPS Growth %: +406.3%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +406.3%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q1 EPS of $0.20, $0.01 better than the analyst estimate of $0.19. Revenue for the quarter came in at $64.8 million versus the consensus estimate of $69.29 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Corcept Announces Planned Leadership Transition
- Top Wealth Group expects net profit to double in fiscal 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
